#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Brain stem glioma Neuroblastoma recurrent Vitamin B12 deficiency Corneal neovascularisation Niemann-Pick disease Dedifferentiated liposarcoma Leiomyosarcoma recurrent Biliary neoplasm Hypomagnesaemia Haemophilia A without inhibitors Becker's muscular dystrophy Intracranial germ cell tumour Stiff person syndrome Li-Fraumeni syndrome Primary biliary cholangitis More trials…

    Learn about Rare Diseases

    Rhabdomyosarcoma recurrent – Life with Disease Advanced systemic mastocytosis Inclusion body myositis – Diagnostics Pemphigoid – Treatment Nodal marginal zone B-cell lymphoma – Life with Disease Alagille syndrome – Basic Information Chondrosarcoma Myxofibrosarcoma – Diagnostics Osteosarcoma metastatic – Basic Information Langerhans’ cell histiocytosis – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Progesterone Tadekinig Alfa Sulfonamides, Urea Derivatives Apocynin Imipramine Hydrochloride Odm-212 Tasipimidine Pertechnetate (99Mtc) Sodium PICLIDENOSON Bupivacaine Hydrochloride Fenofibrate VRDN-003 Levodropropizine TUVATEXIB Levetiracetam CHOLINE ALFOSCERATE Cilazapril Tazobactam Sodium Lidocaine 1,3-BUTYLENE GLYCOL More therapies…

    Learn about Your Condition

    Thrombolysis Vasospasm Anal cancer stage III Drug eruption Cervix carcinoma Bronchostenosis Laryngeal cancer stage II Vitamin D deficiency Hypoxia Cholecystitis acute Pseudoxanthoma elasticum Anaemia of pregnancy Hepatocellular carcinoma Coronary artery dissection T-cell lymphoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Bacterial Infections and Mycoses

  • A study comparing furazidin and clindamycin for women with bacterial vaginosis

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Clindamycin Phosphate
    Czechia Italy Poland Slovakia

  • Study of Switching from Intravenous to Oral Antibiotics in Patients with Infective Endocarditis Using a Drug Combination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Endocarditis
    Investigated Drugs:
    • Amoxicillin Trihydrate
    • Benzylpenicillin Sodium
    • Clindamycin Hydrochloride
    Belgium

  • A study testing the safety and effectiveness of inhaled hypochlorous acid in patients with chronic airway infections

    Recruiting

    1 1 1
    Investigated Diseases:
    • Respiratory tract infection
    Investigated Drugs:
    • HYPOCHLOROUS ACID
    Denmark

  • Testing a Drug Combination for Personalized Sepsis Treatment in Children and Adults with Severe Blood Infection

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Fludrocortisone Acetate
    • Heparin
    • Human Plasma Protein
    France

  • A Study of Group B Streptococcus 6-Valent Polysaccharide Conjugate Vaccine in Healthy Pregnant Women and Their Infants

    Recruiting

    3 1
    Investigated Drugs:
    • GROUP B STREPTOCOCCUS CAPSULAR POLYSACCHARIDE IB CONJUGATED TO DIPHTHERIA TOXIN CRM197
    • STREPTOCOCCUS AGALACTIAE, SEROTYPE II, CAPSULAR POLYSACCHARIDE, CONJUGATED TO CRM197
    • STREPTOCOCCUS AGALACTIAE, SEROTYPE V, CAPSULAR POLYSACCHARIDE, CONJUGATED TO CRM197
    Finland The Netherlands Spain

  • A study on azithromycin for preventing airway infections in children aged 0-72 months with structural lung damage or congenital lung and airway malformations

    Recruiting

    3 1 1
    Investigated Drugs:
    • Azithromycin
    Denmark
Previous Page
1 2 3 4 5 … 46
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!